← Back to all trials
Completed
NCT06948331
RADA16 for Aquablation Day Case
Conditions: Hematuria, Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
Sex: Male
Healthy volunteers: No
Phase: PHASE2
Enrollment: 24
Sponsor: NYU Langone Health
Location: NYU Langone Health New York New York
Summary
This is a pilot proof of concept single-arm study using PuraStat following Aquablation procedure to assess reduction of hematuria to allow for same day discharge.
The primary objective is to assess how PuraStat affects post-operative hematuria following Aquablation.
The secondary objective is to assess the number of patients discharged on the same day based on the hematuria criteria (Grade 0 and Grade I).
Eligibility Criteria
Inclusion Criteria:
• Any man undergoing Aquablation for LUTS due to BPH
Exclusion Criteria:
• Unwilling to sign consent
Source: ClinicalTrials.gov (NCT06948331). StuddyBuddy aggregates publicly available trial information.
